Virtu KCG Holdings’s Edesa Biotech EDSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-101
Closed -$49K 3010
2017
Q1
$49K Buy
+101
New +$53.6K ﹤0.01% 2848
2016
Q3
Sell
-58
Closed -$65K 3144
2016
Q2
$65K Buy
+58
New +$59.8K ﹤0.01% 2623

Other funds holding EDSA

Virtu KCG Holdings's EDSA Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Edesa Biotech (EDSA) in Q2 2017, closing a stake of 101 shares — an estimated $49K sold.

Virtu KCG Holdings first reported a position in EDSA in Q2 2016 and held it in 2 quarters. The position peaked at $65K in Q2 2016. 9 funds tracked by Wall St. Rank hold EDSA as of Q2 2017.

  • Virtu KCG Holdings reported no remaining Edesa Biotech position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 101 Edesa Biotech shares in Q2 2017, an estimated $49K.
  • Virtu KCG Holdings first reported a position in Edesa Biotech in Q2 2016 and held it in 2 quarters.
  • Virtu KCG Holdings's Edesa Biotech position peaked at $65K in Q2 2016.
  • 9 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.